-
assays and preclinical evaluation in mouse models in collaboration with IRMB and PEPCO platform. - Analyze immune evasion, signaling, and therapeutic efficacy. - Benefit from mobility and exchange
-
clinicians, 1 lab manager, 2 bio-informaticians, 3 research technicians, 2 post-doctoral fellows, 5 PhD students and 3 Master students. Most of the studies carried out by our team bridge several of those
-
sophisticated mouse genetic models of cancer and conditional gene targeting, single-cell RNA-seq, spectral flow cytometry, multiplex imaging and spatial genomics data acquisition and analysis. Where to apply E
-
. To achieve our objectives, we will use cutting-edge technologies (CITE-seq, RNA-seq, Ribo-seq) and combine analysis in readily available relevant cellular models of cancer-experienced T cells, syngeneic mouse